EPISODE · May 20, 2025 · 16 MIN
Surg: Testicular Cancer: Free MSRA Podcast
from Pass the MSRA: Free Podcasts · host Pass the MSRA
🎧MSRA Deep Dive:Testicular Cancer – High-Yield, Concise, and Clinically RelevantLet’s cut throughthe noise—this is your rapid yet comprehensive MSRA revision tool on testicular cancer, one of the most commonmalignancies in young men and a frequent exam topic. We’ll walk you througheverything you need: risk factors, presentation, investigations, management,and complications.🧠Key Learning Points📌DefinitionTesticular cancer = malignancy of the germ cells in one or both testicles.Most cases are seminomas or non-seminomatous germ cell tumours (NSGCTs).Peak age: 15–49 years. Highly treatable, especially if caught early.📌Risk FactorsCryptorchidism (undescended testicle)Family or personal historyKlinefelter syndromeInfertility (×3 risk), HIV, mumps orchitisTGCT1 gene, abnormal chromosome 12❗️ Not linked: trauma, vasectomy, microlithiasis📌Symptoms & SignsPainless testicular lump (classic finding)Dull ache, heaviness, or enlargementGynaecomastia (β-HCG secretion)Back pain = possible metastasisOn exam: firm, non-tender lump, usually separate from epididymis⚠️ Rule out torsion, infection, benign lumps like hydroceles or spermatoceles📌Investigations🔍First-line: Scrotal ultrasound🧪Tumour markers:AFP – raised in NSGCTs, not seminomasβ-HCG – raised in NSGCTs and some seminomasLDH – nonspecific but useful for prognosis📸 CT chest/abdomen/pelvis – staging🩺 Important: Normal markers DO NOT rule out cancer📌ManagementOrchidectomy via inguinal approach = first step for allSeminoma:Stage I: surveillance ± single-agent chemo or radiotherapyStage II+: chemo ± radiotherapyNSGCTs:Stage II+: BEP chemotherapy (bleomycin, etoposide, cisplatin)Post-chemo residual mass? → Surgical resection (if non-seminoma)Fertility: Offer sperm banking before treatmentProsthesis offered post-op for cosmetic reasons🚨 2WW referral required for all suspected cases📌PrognosisExcellent if caught early (>95% survival Stage I)Slightly worse for NSGCTs vs seminomasLate relapses rare but possibleMonitoring: Follow-up 5–10 years⚠️ Risk of infertility, hypogonadism, second cancers, CVD📌ComplicationsMetastases (lungs, retroperitoneum, brain)Infertility, hypogonadism, recurrenceLong-term: Chemo side effects (neuropathy, ototoxicity), cardiovascular riskPsychosocial impact (anxiety, financial stress, sexual function)🧠Mnemonics & TipsThink: “Young man + painless lump = testicular cancer until proven otherwise”Markers: “AFP → yolk sac; β-HCG → choriocarcinoma/seminoma”Key ages: Teratomas ~25y, Seminomas ~35y 📎Useful MSRA Links –Testicular Cancer Revision📝 Revision Notes:https://www.passthemsra.com/topic/testicular-cancer-revision-notes/🧠 Flashcards:https://www.passthemsra.com/topic/testicular-cancer-flashcards/💬 Accordion Q&A:https://www.passthemsra.com/topic/testicular-cancer-accordion-qa-notes/🚀 Rapid Quiz:https://www.passthemsra.com/topic/testicular-cancer-rapid-quiz/🩺 MSRA Surgery Course:https://www.passthemsra.com/courses/surgery-for-the-msra/ 🎙️ #MSRA #TesticularCancer #MSRARevision#MSRAFlashcards #MSRAQuiz #Orchidectomy #GermCellTumour #MedicalRevision#FreeMSRA #PassTheMSRA #Seminoma #NSGCT #MSRASurgery #AFP #BEPchemo
Embed this episode
Ready to play
Surg: Testicular Cancer: Free MSRA Podcast
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.